What's happening
This bill ensures ovarian cancer survivors in New York have the right to unrestricted access to genetic and genomic screenings.
Why it matters
Removes insurance and provider barriers. By prohibiting frequency caps or other restrictions on genetic and genomic testing, the bill ensures ovarian cancer survivors can access as many tests as their health situation requires, rather than being limited by insurance rules or provider policies.
Addresses risk of secondary cancers and recurrence. Genetic and genomic profiling, especially for BRCA1/2 and Lynch syndrome mutations, can reveal inherited risks for future cancers (ovarian, breast, colorectal, etc.), empowering survivors to make informed decisions about preventive care and monitoring.
Supports tailored medical care. By allowing treating healthcare professionals to order additional, medically necessary tests beyond standard panels, the legislation enables personalized treatment plans and up-to-date risk assessment, potentially leading to better health outcomes.
Reduces disparities in care. Ensuring unrestricted access to these screenings helps close gaps for patients who might otherwise be denied cutting-edge diagnostics due to cost, lack of coverage, or arbitrary policy limits.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Guarantee Ovarian Cancer Screenings
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Ovarian Cancer Survivor Screenings
In Senate Committee · Rules · Sponsor Roxanne J. Persaud
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
10049
IN ASSEMBLY
April 29, 2022
Introduced by M. of A. SOLAGES -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to ensuring ovarian cancer survivors have the right to access screenings for health conditions
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2404-e to read as follows:
§ 2404-e. Ovarian cancer; right to screenings. No person with a personal history of ovarian cancer shall be denied genetic testing or genomic tumor profiling for inherited germline mutations and acquired somatic mutations, respectively. In general, such testing shall not be subject to frequency caps or other limitations and shall include, but not be limited to:
(a) genetic mutations in BRCA1 and BRCA2 genes;
(b) genetic mutations associated with Lynch syndrome;
(c) rearrangement analysis of all coding exons associated with ovarian cancer; and
(d) additional mutations if medically necessary and appropriate, as determined by the health care professional treating the individual.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14504-02-2
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.